Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 625.00 | 414.82 | 1023.00 | 929.25 | 1.1009 | 1.1722 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 414.82 | 927.00 | 929.25 | 0.9976 | 0.9958 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 1040.00 | 929.25 | 1.1192 | 1.2032 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 625.00 | 414.82 | 931.00 | 929.25 | 1.0019 | 1.0032 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 625.00 | 414.82 | 306.00 | 929.25 | 0.3293 | -0.2301 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 1017.00 | 929.25 | 1.0944 | 1.1613 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 414.82 | 1115.00 | 929.25 | 1.1999 | 1.3391 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 967.00 | 929.25 | 1.0406 | 1.0696 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 625.00 | 414.82 | 427.00 | 929.25 | 0.4595 | 0.0252 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 625.00 | 414.82 | 710.00 | 929.25 | 0.7641 | 0.5870 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 696.00 | 929.25 | 0.7490 | 0.5601 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 625.00 | 414.82 | 371.00 | 929.25 | 0.3993 | -0.0915 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 977.00 | 929.25 | 1.0514 | 1.0880 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 1199.00 | 929.25 | 1.2903 | 1.4897 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 625.00 | 414.82 | 632.00 | 929.25 | 0.6801 | 0.4360 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 397.00 | 929.25 | 0.4272 | -0.0370 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 625.00 | 414.82 | 1176.00 | 929.25 | 1.2655 | 1.4486 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 880.00 | 929.25 | 0.9470 | 0.9086 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 414.82 | 514.00 | 929.25 | 0.5531 | 0.2023 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 625.00 | 414.82 | 759.00 | 929.25 | 0.8168 | 0.6807 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 951.00 | 929.25 | 1.0234 | 1.0402 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 759.00 | 929.25 | 0.8168 | 0.6807 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 424.00 | 929.25 | 0.4563 | 0.0190 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 754.00 | 929.25 | 0.8114 | 0.6712 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 803.00 | 929.25 | 0.8641 | 0.7641 |